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Abstract: Cancer-related fatigue (CRF) is a debilitating adverse effect among children with cancer and
a significant barrier to physical activity (PA) participation. PA interventions are effective at reducing
fatigue and improving both quality of life (QOL) and functional outcomes in children with cancer.
However, 50–70% of children with cancer do not meet PA guidelines. Thus, adjuvant methods are
needed to increase PA participation. Given the growing interest in the use of beetroot juice to reduce
exercise-induced fatigue, our narrative review evaluated the potential use of beetroot to improve PA
participation to counter CRF and improve QOL. Our review of 249 articles showed a lack of published
clinical trials of beetroot in children and adults with cancer. Trials of beetroot use had been conducted
in a noncancer population (n = 198), and anticancer studies were primarily in the preclinical phase
(n = 40). Although results are promising, with beetroot juice shown to counter exercise-induced
fatigue in a variety of athletic and patient populations, its use to counter CRF in children with cancer
is inconclusive. Pilot and feasibility studies are needed to examine the potential benefits of beetroot
to counter CRF, increase PA participation, and improve QOL in children with cancer.
Keywords: neoplasms; beetroot; betalains; exercise; childhood cancer; pediatric cancer;
fatigue; nutrition
1. Introduction
1.1. Cancer-Related Fatigue and Its Impact on Pediatric Cancer Patients
Childhood cancer is the second leading cause of death among children aged 1 to 14 years in the
United States [1]. Based on the latest estimate, approximately 10,590 children (<15 years old) will be
diagnosed as having cancer in the United States [1]. With advanced diagnosis and treatment, the 5-year
survival rate is now more than 80% in children [2]. However, cancer treatment is associated with
a multitude of adverse effects [3,4]. Cancer-related fatigue (CRF) is one of the most significant and
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debilitating problems associated with cancer treatment [3,5] and often persists even after treatment has
ended [6]. CRF is defined as distressing, pervasive symptoms with physical, mental, and emotional
components characterized by a lack of energy [5,7]. Children describe CRF in terms of physical
sensations such as tiredness, sleepiness, lack of energy, and lack of desire to interact and participate in
daily activities [5]. In addition, an increase in fatigue has been associated with poor sleep quality [8],
a decrease in sleep duration [9,10], sleep disturbances [11], and decreased physical performance [12].
Furthermore, CRF has been associated with depression [5,13] and poor neurocognitive outcomes
represented by poorer performance in task efficiency and memory tests [14]. Thus, CRF ultimately
affects the quality of life (QOL) of children with cancer by impeding patients’ ability to engage in daily
activities [15]. As a result, there is a growing interest in developing non-pharmacological interventions
to minimize fatigue and its negative impact on pediatric cancer patients [16,17].
1.2. Critical Role of Physical Activity among Children with Cancer
Multiple non-pharmacological interventions have been developed to reduce fatigue in children
with cancer [16,17]. These include exercise, massage, healing touch, music therapy, acupressure,
and health education [16,17]. Reviews of the literature have found that physical activity (PA) is the most
frequent target for intervention [16,17]. PA is defined as the movement of the body supported by the
skeletal muscle with energy expenditure. This differs from the term exercise. Exercise is a subcategory of
PA with the goal of improving one or more areas of physical fitness by following a planned, structured,
and repetitive exercise program [18]. Given that children with cancer spend more time engaging in
sedentary behavior (e.g., screen-time) than do children without cancer, promoting engagement of any
type of PA is critical to help maintain physical function [19]. For example, a nonrandomized trial showed
that supervised aerobic and resistance exercise sessions during treatment were able to significantly
improve functional capacity and body mass in children who were undergoing hematopoietic stem cell
transplantation [20].
Furthermore, systematic reviews with and without meta-analyses of randomized controlled trials
indicated that PA interventions significantly decreased fatigue and stress [16] and produced a large
effect size of −0.76 in reducing general fatigue in children with cancer [21]. Researchers used various
exercise interventions of lengths ranging from two days to 16 weeks [16,21]. Most of the studies
focused on promoting aerobic exercise training [16,21]. Aerobic exercises were implemented with the
use of compact discs for home-based interventions, bicycle-style exercisers in the clinic, or supervised
training sessions [16,21]. The target exercise intensity from interventions ranged from 60% to 90%
of maximum heart rate within a 25- to 45-minute exercise session [21]. Across reviews, only two
studies [22,23] included a core strength and flexibility training component. Although limited by small
sample sizes and various types of exercise interventions, the aforementioned studies showed that
PA (both aerobic and resistance exercises) plays a critical role in mitigating fatigue and in improving
function during and after active cancer treatment in children with cancer.
Despite evidence showing that PA in children with cancer during treatment is safe and has
positive benefits (i.e., decreased fatigue, improved physical fitness and motor function, and improved
QOL) [24,25], 50–70% of children with cancer do not meet the PA guidelines of 60 min of aerobic
exercise and muscle strengthening or bone-strengthening activities per day [26]. Evaluation of PA levels
using accelerometers confirmed that children with acute lymphoblastic leukemia had significantly
lower levels of total weekly moderate-to-vigorous physical activity (328 ± 107 min) than did control
children (506 ± 175 min) [27]. Furthermore, a recent meta-analysis of observational studies showed
that children with cancer had significantly lower levels of PA (g = −0.889) and fitness (g = −1.435)
than did controls without cancer [28]. Additionally, the adherence rate of children with cancer to PA
interventions ranged widely, from 25% to 100% [25]. Therefore, innovative methods are needed to
promote PA initiation and adherence among childhood cancer survivors.
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1.3. Benefits and Risks of Dietary Nitrate
One possible method to augment PA participation may be the use of beetroot juice as a supplement
during cancer treatment. Researchers have found that beetroot has been used as an alternative medicine
in cancer patients around the globe [29]. This is because beetroot has been viewed as a “medicinal
food” since ancient times [29]. Nikolic et al. found that more than half (~57%) of gastrointestinal cancer
patients (n = 193) reported using beetroot juice in conjunction with conventional oncology treatment [30].
Arrko et al. found that 45% of Finnish cancer patients (n = 151) have used a variety of unproven
cancer remedies; among these patients, approximately 10.3% have tried or were using beetroot as an
alternative remedy [31]. In addition, Clement et al. looked at the most commonly used herbal remedies
and functional foods among prostate, breast, and colorectal cancer patients (n = 150) in Trinidad [32] and
found that 19.3% of the patients used beetroot, either juiced or blended, during treatment. In addition,
they found that 47.3% of patients believed that supplementation of beetroot during treatment was
beneficial in managing their cancer diagnosis. Furthermore, there is growing evidence of health benefits
from the high natural nitrate content in beetroot juice [33]. Some of these benefits include enhanced
exercise performance, increased exercise tolerance, reduced exercise-related fatigue, inhibited cancer
proliferation, and reduced adverse effects associated with anthracyclines [29,33–36]. This is because
dietary nitrate from vegetables, such as beetroot, is an important source of nitric oxide (NO) in the
nitrate–nitrite–NO pathway [37]. Researchers have found that it is through this pathway that natural
nitrate compounds have a positive impact on health [37,38].
Nitrate (NO3-)—a compound that naturally occurs in vegetables—has been used as a preservative,
specifically in processed meats [37,39]. Through the interaction with bacteria in the mouth or enzymes in
the body, nitrates are then turned into nitrites (NO2-). Nitrites can then become NO or nitrosamines [39].
Nitrosamines are a known carcinogen associated with increased bowel cancer; they occur when nitrites
combine with a source of amines (e.g., protein-rich foods) [37,38,40]. Nitrosamines can also occur when
meats are cooked with high heat. In contrast, nitrites formed from vegetable sources have been found
to encourage NO formation and inhibit nitrosamine formation [37,40]. This is because nitrites from
vegetable sources are combined with protective components like vitamin C, polyphenols, and fiber that
promote NO formation. Thus, the World Health Organization’s International Agency for Research on
Cancer (IARC) concluded in 2006 that dietary nitrate consumed without the presence of antioxidants is
probably carcinogenic [37,40]. Furthermore, although dietary nitrates from vegetable sources are now
considered to be safe [37,38,41], excessive levels of nitrates (>10 mg/L) from drinking water have been
associated with methemoglobinemia in infants (<6 months old) and in those whose conditions inhibit
the conversion of methemoglobin to hemoglobin [42]. However, such excessive consumption of dietary
nitrate through food sources is hard to achieve unless the drinking water has been contaminated with
fertilizers in the groundwater [42].
2. Methods
Similar to the review completed by Kapadia in 2012 [29], our literature search was conducted with
the assistance of a research librarian. It yielded no clinical trials that evaluated the use of beetroot juice
in children with cancer (Table 1). The search terms that we used included beet, sugar beet, beta vulgaris,
betanin neoplasm/cancer, pediatrics/paediatric, adolescent, endurance, fatigue, athletic performance,
and stamina. Databases that the librarian searched included Embase, Medline, and Cochrane.
Articles were first screened by title, abstract, and whether they were written in the English-language
by authors MCS and KA. The full-text of the articles was pulled for review if outcomes of interest
corresponded with our research question. Additional articles were identified by examining reference
lists and from expert input. Of the 249 articles that were selected for review, all 198 clinical trials
associated with the use of beetroot juice had been conducted in a noncancer population, and the
40 anticancer studies were primarily in the preclinical phase. The remaining 11 studies consisted of a
combination of review articles and mechanistic studies associated with the use of beetroot to increase
exercise endurance and within various disease conditions using animal and cell models. Therefore,
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the goal of our narrative review was to compile evidence from studies examining the effects of beetroot
on chemoprevention and exercise-induced fatigue to evaluate its potential to combat CRF, increase PA
participation and improve QOL in children with cancer.
Table 1. Search terms used for the narrative review.
1 exp beet/ or exp sugar beet/ 3268
2 (beet * or “Beta vulgaris” or Betanin).ab,ti. 18,668
3 1 or 2 19,159
4 exp neoplasm/ 4,623,242
5 (cancer * or neoplasm * or leuk * or lymphoma *).ab,ti. 3,205,201
6 4 or 5 5,412,111
7 3 and 6 [broad, beets and cancer] 482
8 exp athlete/ 53,800
9 exp performance/ 32,549
10 exp endurance/ 23,154
11 (athlete * or performance * or endurance * or cardio *).ab,ti. 2,218,686
12 8 or 9 or 10 or 11 2,240,627
13 3 and 12 [beets and athletic performance and stamina] 1180
14 exp pediatrics/ 113,020
15 (child * or pediatric * or paediatric * or adolescen * or infant *).ab,ti. 2,520,664
16 14 or 15 2,544,678
17 3 and 16 [beets and pediatric population] 213
18 7 or 13 or 17 1809
19 Beetle.ab, ti. 18,518
20 18 not 19 1312
3. Current Research on Beetroot and Cancer
In our review of the literature on beetroot use in cancer research, we found that the focus has been
primarily on evaluating beetroot’s potential chemopreventive and anticancer effects using cancer cell
lines [29,35]. Briefly, the chemopreventive and anticancer effects of beetroot and its compounds occur
through several mechanisms such as: inducing cell apoptosis, reducing oxidase activity, disrupting
inflammation, increasing anti-inflammatory cytokines, and acting as a cytotoxin [29,35]. Studies within
the past decade have found that beetroot was able to suppress the growth of breast cancer cells (MCF-7)
in a dose-dependent manner [43], that fermented beetroot juice was able to decrease the average
number of aberrant crypt foci in rat colons [44], that a beet-rich diet was able to decrease the incidence
and amount of aberrant crypt foci in male rats [45], and that the addition of beetroot extract resulted in
a slower rate of proliferation of esophageal papilloma in rats [35]. These studies used a wide range of
dosages in cell and animal studies to examine the various beetroot compounds’ anticancer functions.
At this time, additional research is needed to determine clinically relevant doses of beetroot that can be
used in humans.
Other research with cell lines has examined beetroot as an adjuvant to anthracyclines chemotherapy.
Anthracyclines (such as doxorubicin) are a class of chemotherapy drugs that are commonly used to
treat many types of cancer, yet are also well known to cause cardiotoxicity [46]. Researchers theorized
that since betanin (a beetroot compound) has a chemical structure similar to that of doxorubicin,
beetroot might exhibit similar cytotoxic effects on cancer cells [47], and adjuvant therapy might lead to
a reduced dosage of doxorubicin, thus reducing cardiotoxicity. Kapadia et al. found that in prostate
cancer (PC-3) and breast cancer (MCF-7) cell lines, red beetroot extract exhibited dose-dependent
cytotoxic effects similar to those of doxorubicin, but overall, the cytotoxic effects of red beetroot extract
were significantly lower [47]. Another group, Das et al., showed that after a combination of beetroot
juice and doxorubicin was given to the adult rats, the beetroot reduced cardiotoxicity and cardiac
cell deaths in the cardiomyocytes [34]. Furthermore, Das et al. found that using a combination
of beetroot juice and doxorubicin, compared with use of doxorubicin alone, significantly increased
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doxorubicin-mediated apoptosis in breast cancer cells [34]. These important studies in cell lines and
animal models highlight the possibility of using beetroot to treat cancer and attenuate cardiotoxicity
and illustrate the potential usefulness of beetroot as an adjuvant therapy; however, they provide little
information on the potential of beetroot to reduce cancer-related fatigue as a means to promote PA.
Furthermore, given the potential interaction between beetroot supplementation and conventional
neoadjuvant/adjuvant anticancer therapy, the safety of its use during treatment needs to be evaluated
in future pilot trials among children and adults with cancer.
4. The Use of Beetroot Juice in Cancer Patients
Our literature search revealed no published clinical trial results on beetroot used as a supplement
to modify PA levels or reduce fatigue in adults or children with cancer. However, our search of
ClinicalTrials.gov revealed a total of five trials registered to evaluate the use of dietary beetroot
in cancer patients. The outcomes being investigated include aerobic performance, cardiovascular
function, muscle strength, and/or body composition and/or treatment-related symptoms. Table 2
provides a summary of the targeted population, outcomes of interest, and the type and dosages
of beetroot supplements proposed by the studies. Currently, two studies are ongoing (one not yet
recruiting [NCT03944226] and one enrolling [NCT03776149]), two had unknown status (NCT023193560;
NCT02044562) and one study finished without achieving its recruitment goal (NCT02058849). The sole
study (NCT02058849) reporting results compared a supplement of 10 g of beetroot powder (BEETELITE
™ NeO shot) mixed in 4–8 oz of water to placebo. Since the trial ended with only one person in the
placebo group, a comparison between groups could not be conducted.
Table 2. Registered trials in ClinicalTrials.gov investigating beetroot supplement in cancer patients.
NCT Trials CancerPopulation
Outcomes
Investigated Duration Dosage Brand
03944226 Breast Cancer
Lipid composition
in tumor and
breast tissue;
water displacement
in tumor
5-day dietary
nitrate
intervention
3 doses of
7 cL/70 mL (0.4 g
nitrate/dose) of
concentrated
beetroot juice/day
James White
Drinks, UK
03776149
Cancer
Survivor with
History of
Anthracycline
Chemotherapy
Left ventricular
function
7-day dietary
nitrate
(beetroot juice)
140 mL/day
Beet It
(Heart-Beet
Ltd.)
02058849 Head and NeckCancer
Adherence and
endurance at
6 weeks and
12 weeks
Up to 6 weeks
10 g beetroot
crystals mixed with
4–8 oz of water/day
BEETELITE™
NeO shot
02319356 NasopharyngealCarcinoma
Anaerobic
threshold;
VO2Max
7-day dietary
nitrate
NO3- 6.2 mmol/day
(500 mL)
Beet It Sport
Shots, James
White Drinks,
UK
02044562 ColorectalCancer Plasma nitrate level
7-day dietary
nitrate
70 mL/day
(0.45 g nitrate) Did not report
As mentioned previously, despite the lack of clinical trials evaluating the effectiveness of beetroot
juice in cancer patient populations, researchers have found that beetroot has been used as an alternative
medicine in cancer patients around the globe [29]. Further, 67.4% of cancer patients stated that they
were satisfied with their use of herbal remedies/functional foods, and 90% said they would continue to
use the herbal remedies/functional foods in the long-term [32]. The top two reasons for using alternative
medicine across all three studies were (1) patients believed it would be health-restoring and/or increase
their chance of being cured [30–32] and (2) patients had heard about the benefits of this alternative
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medicine from other cancer patients [30–32]. The reports from Nikolic et al. [30], Arrko et al. [31],
and Clement et al. [32] have all collected self-reported information on the use and benefits of beetroot,
so they do not present rigorous evidence of the adverse events or benefits associated with beetroot
supplements in cancer patients. Since beetroot is often used as an alternative medicine in conjunction
with conventional anticancer therapy, feasibility and proof-of-concept pilot trials are needed to help
formalize adverse events and establish the potential benefits of beetroot supplements on various cancer
and treatment-related outcomes such as those presented in Table 2.
5. Effects of Beetroot on Exercise Tolerance in Athletes and Disease Populations
Given the sparsity of evidence in the literature describing beetroot’s effect on cancer-related
fatigue, we compiled evidence of beetroot’s ability to reduce fatigue in athletes and disease populations
to illustrate beetroot’s potential feasibility to intervene with cancer-related fatigue.
5.1. Exercise Tolerance in Athletes
In the past decade, interest has been growing in the effects of beetroot juice on exercise tolerance
and fatigue. This interest initially stemmed from a study by Larsen et al., who found that dietary nitrate,
which beetroot contains in abundance, reduces—presumably via conversion to nitric oxide (NO)—the
O2 cost of submaximal exercise, thereby improving muscular efficiency [48]. Because efficiency is a key
determinant of aerobic exercise performance, it was reasonable to assume that this nitrate-induced
reduction in work demand could enhance performance by increasing exercise tolerance and delaying
the onset of fatigue [41].
Although nitrate is not believed to possess any specific physiological function, its conversion to the
free radical NO can mediate a multitude of beneficial effects. As previously mentioned, the production
of NO from nitrate starts in the small intestine, where the highly bioavailable nitrate is absorbed into
the circulation [49]. Approximately 25% of the nitrate is taken up by the enterosalivary cycle, where it
can be reduced to nitrite [50]. The generation of NO occurs when the salivary nitrite is reabsorbed into
the circulation via the stomach, where it is metabolized to NO by a variety of reductase enzymes [50].
The detailed processes involved are described elsewhere [50].
The first study to report the ergogenic potential of nitrate-rich beetroot was conducted by Bailey
et al., who measured exercise efficiency in eight healthy male volunteers after they ingested beetroot
juice (500 mL/day, nitrate; 11.2 mmol) or a nitrate-free, low-calorie, blackcurrant cordial (control) for
6 days [36]. They found that beetroot juice elicited a 5% reduction in whole-body O2 consumption
(e.g., improved efficiency) during a sub-maximal cycling task equivalent to 80% of the pulmonary gas
exchange threshold (GET). Furthermore, those randomized to the beetroot juice intervention group
exhibited a 16% longer time to fatigue [36] compared with controls who underwent the same vigorous
exercise activity [36]. These findings were confirmed by several further studies, in which beetroot juice
was shown to extend the time to fatigue by 25% during high-intensity knee-extensor exercise [51];
by 15% during high-intensity running activity [52], and by 3.5% during intermittent cycling exercise [53].
Beetroot juice has also been shown to enhance peak power output during cycling [54] and maximal
strength in response to electrical stimulation [55] and during voluntary muscle contractions [56].
Two of the aforementioned studies [52,53] and several others since (see [41] for review) have used a
nitrate-depleted, but otherwise nutritionally identical, beetroot juice drink as a placebo, suggesting that
nitrate was the bioactive constituent largely responsible for these beneficial physiological effects.
However, recent research has shown that betalains, the group of pigments found in beetroot that
provide its purple hue, can also increase exercise tolerance in healthy young subjects, indicating that
nitrate might not be the only ingredient in beetroot with ergogenic effects [57,58]. Although the
mechanisms underpinning such improvements are unclear, betalains are known to have potent
antioxidant effects [33]. Such effects are believed to attenuate exercise-induced oxidative stress,
which has been associated with fatigue during high-intensity exercise [59]. Thus, the betalains present
in beetroot could enhance exercise performance independent of any physiological effects of nitrate and
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its subsequent conversion to NO [58–60]. Finally, a study by Porcelli et al. found that a short-term
high-nitrate diet (~8.2 mmol/day of nitrate) significantly improved exercise performance compared
with performance associated with the control diet (~2.9 mmol/day of nitrate) [61], suggesting that
future studies are needed to examine the effects of beetroot juice on exercise performance compared
with the effects of a high-nitrate diet from other vegetable sources.
5.2. Exercise Tolerance in Populations with Various Disease Conditions
Far fewer studies have investigated whether beetroot supplementation can improve exercise
tolerance and reduce fatigue in populations with various disease conditions (see [62] for a review).
Of those that have, most studies of beetroot’s effects on health have focused on persons with
cardiovascular disease (CVD), who typically have a reduced aerobic capacity, exercise intolerance, and
an early onset of fatigue during both physical activity and daily living tasks [63]. In one of the first of
these studies, Kenjale et al. investigated the influence of a pre-exercise dose of beetroot juice (500 mL)
on exercise tolerance in patients with peripheral arterial disease [64]. They showed that beetroot
juice significantly extended time to exhaustion (+ 18%) during a controlled treadmill-walking task in
comparison to a placebo (orange juice). They also reported increases in total hemoglobin concentration
in the gastrocnemius muscle, as measured by near-infrared spectroscopy, suggesting that beetroot
juice might have stimulated peripheral vasodilation and tissue oxygenation in the ischemic region [64].
More recently, Coggan et al., reported that ingesting beetroot juice before sub-maximal cycling exercise
extended time to fatigue by 7% compared to a placebo in heart-failure patients [65].
As for other disease conditions, a recent study also found that beetroot juice improved exercise
tolerance in obese adolescents, another population with poor aerobic capacity and exercise intolerance.
This study found that beetroot juice could be used to combat the early onset of fatigue associated
with exercise in this population [66]. Similarly, Berry et al. and Curtis et al. found that beetroot
juice supplementation in individuals with chronic obstructive pulmonary disease (COPD) resulted
in extended exercise time during submaximal exercise, decreased resting systolic blood pressure,
lowered VO2 consumption during submaximal exercise, and decreased diastolic blood pressure [67,68].
The favorable effects of beetroot juice do not appear to be limited to aerobic exercise; benefits for
muscle strength have also been reported. In one such study, in an elderly population, de Oliviera et al.
found that acute intake of a beetroot-based gel attenuated the decline in handgrip strength following
fatiguing handgrip exercise, indicating that beetroot juice might also be useful for counteracting the
decline in muscle strength and power associated with age [69,70].
It is important to note that not all studies report favorable effects with beetroot juice, both in healthy
populations and in those with various disease conditions [62]. In the latter population, several studies
found no differences in exercise tolerance from beetroot juice ingestion in patients with CVD [71,72] or
type 2 diabetes [73,74] or individuals with COPD [75–77]. The equivocal findings in studies to date are
believed to be due to differences in the nitrate dose used, exercise mode, populations, and/or potential
interference from concomitant medications [62]. Nevertheless, a meta-analysis of studies conducted in
healthy populations suggested that dietary nitrate (beetroot juice or sodium/potassium nitrate) does
have a small to moderate beneficial effect on exercise performance [78]. When coupled with studies
showing positive effects in various disease populations, it appears that beetroot juice does hold promise
as a dietary supplement to combat exercise intolerance and fatigue and warrants further research.
5.3. Mechanisms of Exercise Tolerance Effect
The mechanisms by which beetroot enhances exercise tolerance are not well-understood.
One potential explanation, presented by Bailey et al., is that nitrate, via its conversion to NO,
reduces the adenosine triphosphate (ATP) cost of muscle contraction, possibly by downregulating
the energy required for intramuscular calcium handling (i.e., actomyosin-ATPase and Ca2+-ATPase
activity) [36,51]. There is also convincing evidence that the ergogenic effects of beetroot juices are
mediated by nitrate-induced structural alterations in the mitochondria. This was demonstrated by
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Larsen et al., who obtained muscle biopsies from 14 healthy participants after 3 days of sodium
nitrate supplementation (0.1 mmol kg-1, day-1) or a placebo control [79]. They found that nitrate
supplementation decreased the mitochondrial protein content of two transporter proteins involved
in ATP/adenosine diphosphate (ADP) proton uncoupling during hydrolysis: adenine nucleotide
translocase (ANT) and mitochondrial uncoupling protein 3 (UCP-3). This decrease translated to
reduced energy (ATP) loss during ATP hydrolysis and was reflected by a 23% increase in ATP
production. The net result was a 19% improvement in the oxidative phosphorylation ratio, or in other
words, a more efficient use of O2 to produce energy during muscular contraction [79].
Alternatively, a number of studies provided evidence that adding nitrate-rich beetroot juice
(1 mmol kg-1, day-1) to a rat’s diet for 5 days augments type IIb fiber-specific blood flow during
submaximal running exercise [80,81]. Therefore, it cannot be ruled out that the ergogenic effects of
nitrates are, at least in part, due to improved local perfusion and muscle oxygenation in more anaerobic
muscle fibers, thereby reducing muscle metabolic perturbation (i.e., Phosphocreatine depletion,
blood lactate accumulation) during exercise [41]. Of course, these effects might operate in tandem
or perhaps are even cumulative [82]. For a more detailed review of the mechanisms of beetroot’s
ergogenic potential see the review conducted by Jones et al. [41].
6. Conclusions and Future Directions
The goal of this narrative review was to provide an overview of the use of beetroot juice in cancer
in the context of previous systematic reviews. Despite apparent widespread use among patients as
complementary medicine, beetroot juice has not been widely studied in this context. Trials registered in
ClinicalTrials.gov showed that researchers are beginning to evaluate the potential use of dietary beetroot
juice in adult cancer patients to improve aerobic performance, cardiovascular function, muscle strength,
body composition, and/or decrease treatment-related symptoms, but this research has not yet been
published to our knowledge. Through our brief review of preclinical evidence and from clinical trial
evidence in athlete and diseased populations, beetroot and its constituents appear to hold promise to
counter exercise intolerance and fatigue, but its use for such a purpose in children with cancer remains
inconclusive and needs to be examined in proof-of-concept pilot studies. Thus, our review points to a
new direction in which beetroot has the potential to be used as an adjuvant strategy to improve PA
participation to counter CRF in children with cancer.
Further, our findings suggest that pilot and feasibility trials will be a critical next step. Information
on safety and potential adverse effects is needed due to the widespread use of beetroot juice as a
supplement in cancer patients. Currently, there is no clear evidence of adverse events associated with
beetroot supplementation or of the benefits of beetroot supplements in cancer patients. Given that
beetroot and its constituents have been shown to mitigate some of the negative effects of cancer on cell
lines and to counter exercise-induced fatigue in young and diseased populations, there is a rationale to
examine its potential benefits for reducing CRF in children with cancer, in a manner similar to that in
the ongoing trials in adults with cancer. More research is needed to (1) delineate the anticancer and
CRF reduction mechanism(s) of action in tandem with traditional anticancer treatment, (2) move from
preclinical testing to pilot and feasibility studies to formally evaluate the safety and potential efficacy
of beetroot juice supplementation in the pediatric cancer patient population to reduce fatigue during
exercise, and (3) assess the potential synergistic effect of beetroot with standard anticancer drugs to
potentially reduce their adverse effects.
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